This study is a cross-sectional study of patients with diabetes. The main purpose of this study is to explore the relationship between inflammatory indicators, but not limited to inflammatory indicators, and diabetes complications, in order to find early predictors and screen out high-risk groups.
Eligibility
Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients with a normative diagnosis of type 2 diabetes
* Age ≥20 years old, regardless of gender
* From January 2018 to August 2023, he was treated in Nanfang Hospital
Exclusion Criteria:
* In the acute infection phase
* The researchers judged that it was not suitable to participate in this study
Primary outcome measure(s)
C-reactive protein — In November-december 2024 Data on inflammatory markers measured during hospitalization were collected in international units. C-reactive protein was measured and reported by the clinical laboratory of Nanfang Hospital under the condition of fasting.
Trial sites (1)
Facility
City
Region
Status
Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University
Guangzhou
Guangdong
Recruiting
More Nanfang Hospital, Southern Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.